Assignee
NEORX CORP
US·158 granted patents·11 pending applications·12,239 citations·filing 1985–2005
Top patents by PatentIndex Score
169 records- 0199US6663881B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted Dec 16, 2003·178 cites·13 claims
- 0299US6569441B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted May 27, 2003·213 cites·10 claims
- 0399US6491938B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted Dec 10, 2002·166 cites·18 claims
- 0499US6171609B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1995·Granted Jan 9, 2001·496 cites·73 claims
- 0599US5981568ATherapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1997·Granted Nov 9, 1999·682 cites·56 claims
- 0699US5733925ATherapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1996·Granted Mar 31, 1998·1k cites·28 claims
- 0799US5391723AOligonucleotide conjugatesNEORX CORP·Filed 1993·Granted Feb 21, 1995·1.1k cites·14 claims
- 0898US6599928B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted Jul 29, 2003·106 cites·43 claims
- 0998US6515009B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1995·Granted Feb 4, 2003·258 cites·72 claims
- 1098US6268390B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1999·Granted Jul 31, 2001·210 cites·18 claims
- 1198US6117911ACompounds and therapies for the prevention of vascular and non-vascular pathologiesNEORX CORP·Filed 1998·Granted Sep 12, 2000·219 cites·18 claims
- 1298US5811447ATherapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1995·Granted Sep 22, 1998·402 cites·18 claims
- 1398US5169933ACovalently-linked complexes and methods for enhanced cytotoxicity and imagingNEORX CORP·Filed 1989·Granted Dec 8, 1992·409 cites·15 claims
- 1498US4897255AMetal radionuclide labeled proteins for diagnosis and therapyNEORX CORP·Filed 1987·Granted Jan 30, 1990·275 cites·9 claims
- 1597US6410587B1Compounds and therapies for the prevention of vascular and non-vascular pathologiesNEORX CORP·Filed 2000·Granted Jun 25, 2002·94 cites·35 claims
- 1697US6306421B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1997·Granted Oct 23, 2001·227 cites·36 claims
- 1797US5112954AMethod of enhancing the effect of cytotoxic agentsNEORX CORP·Filed 1988·Granted May 12, 1992·147 cites·9 claims
- 1896US6358989B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1999·Granted Mar 19, 2002·135 cites·20 claims
- 1996US5521290ATargeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages and methods for their preparationNEORX CORP·Filed 1994·Granted May 28, 1996·77 cites·17 claims
- 2095US5595722AMethod for identifying an agent which increases TGF-beta levelsNEORX CORP·Filed 1995·Granted Jan 21, 1997·182 cites·7 claims
- 2195US5037630AMetal radionuclide labeled proteins for diagnosis and therapyNEORX CORP·Filed 1989·Granted Aug 6, 1991·51 cites·9 claims
- 2295US4965392AChelating compounds for metal-radionuclide labeled proteinsNEORX CORP·Filed 1988·Granted Oct 23, 1990·123 cites·6 claims
- 2394US7084171B2Compounds and therapies for the prevention of vascular and non-vascular pathologiesNEORX CORP·Filed 2004·Granted Aug 1, 2006·41 cites·18 claims
- 2494US5599844APrevention and treatment of pathologies associated with abnormally proliferative smooth muscle cellsNEORX CORP·Filed 1995·Granted Feb 4, 1997·99 cites·18 claims
- 2594US5116944AConjugates having improved characteristics for in vivo administrationNEORX CORP·Filed 1989·Granted May 26, 1992·170 cites·10 claims
- 2693US6217869B1Pretargeting methods and compoundsNEORX CORP·Filed 1997·Granted Apr 17, 2001·209 cites·9 claims
- 2793US5770609APrevention and treatment of cardiovascular pathologiesNEORX CORP·Filed 1995·Granted Jun 23, 1998·154 cites·56 claims
- 2893US5106951AAntibody conjugatesNEORX CORP·Filed 1989·Granted Apr 21, 1992·133 cites·12 claims
- 2993US5075099AMetal radionuclide chelating compounds for improved chelation kineticsNEORX CORP·Filed 1990·Granted Dec 24, 1991·121 cites·13 claims
- 3092US5563250ACleavable conjugates for the delivery and release of agents in native formNEORX CORP·Filed 1994·Granted Oct 8, 1996·146 cites·3 claims
- 3192US5135736ACovalently-linked complexes and methods for enhanced cytotoxicity and imagingNEORX CORP·Filed 1988·Granted Aug 4, 1992·98 cites·13 claims
- 3292US4988496AMetal radionuclide chelating compounds for improved chelation kineticsNEORX CORP·Filed 1988·Granted Jan 29, 1991·142 cites·13 claims
- 3391US6528627B1Bridged aromatic substituted amine ligands with donor atomsNEORX CORP·Filed 2000·Granted Mar 4, 2003·24 cites·15 claims
- 3491USRE38008EMethods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereofNEORX CORP·Filed 2001·Granted Feb 25, 2003·42 cites·35 claims
- 3591US5252713APolymeric carriers for non-covalent drug conjugationNEORX CORP·Filed 1988·Granted Oct 12, 1993·121 cites·18 claims
- 3691US5202451AAnchimeric radiometal chelating compoundsNEORX CORP·Filed 1988·Granted Apr 13, 1993·27 cites·22 claims
- 3790US6767531B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2001·Granted Jul 27, 2004·29 cites·13 claims
- 3890US6416738B1Pretargeting methods and compoundsNEORX CORP·Filed 2000·Granted Jul 9, 2002·32 cites·20 claims
- 3990US6177551B1Bridged aromatic substituted amine ligands with donor atomsNEORX CORP·Filed 1999·Granted Jan 23, 2001·32 cites·23 claims
- 4090US5679318AStable therapeutic radionuclide compositions and methods for preparation thereofNEORX CORP·Filed 1994·Granted Oct 21, 1997·34 cites·11 claims
- 4190US5608060ABiotinidase-resistant biotin-DOTA conjugatesNEORX CORP·Filed 1993·Granted Mar 4, 1997·100 cites·9 claims
- 4290US5322678AAlteration of pharmacokinetics of proteins by charge modificationNEORX CORP·Filed 1988·Granted Jun 21, 1994·120 cites·11 claims
- 4390US4885153ARadiohalogenated for proteinsNEORX CORP·Filed 1989·Granted Dec 5, 1989·24 cites·24 claims
- 4490US4867962AFunctionally specific antibodiesNEORX CORP·Filed 1988·Granted Sep 19, 1989·73 cites·40 claims
- 4589US5541287APretargeting methods and compoundsNEORX CORP·Filed 1994·Granted Jul 30, 1996·87 cites·10 claims
- 4689US5094848ACleavable diphosphate and amidated diphosphate linkersNEORX CORP·Filed 1989·Granted Mar 10, 1992·140 cites·27 claims
- 4789US5021556AMethod of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclidesNEORX CORP·Filed 1988·Granted Jun 4, 1991·96 cites·20 claims
- 4889US4906452ATrichothecene conjugates and methods of useNEORX CORP·Filed 1988·Granted Mar 6, 1990·46 cites·7 claims
- 4988US7070759B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2005·Granted Jul 4, 2006·9 cites·29 claims
- 5088US5545569APrevention and treatment of pathologies associated with abnormally proliferative smooth muscle cellsNEORX CORP·Filed 1995·Granted Aug 13, 1996·70 cites·12 claims
Showing the top 50 of 169 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →